HOME >> MEDICINE >> NEWS
UCI receives major grant to study how acupuncture can treat cardiovascular ailments

Irvine, Calif., Feb. 5, 2004 -- The Susan Samueli Center for Integrative Medicine at UC Irvine has received a $2 million, five-year federal grant to continue studying how an ancient Eastern healing treatment can help treat cardiovascular illnesses such as heart disease, hypertension and arrhythmias.

The grant extends a previous five-year grant from the National Heart, Lung and Blood Institute. Dr. John Longhurst -- UC Irvine cardiologist and director of the center -- received the grant and will continue leading research into how acupuncture triggers physiological changes in the brain that can reverse illnesses that impact millions of Americans.

The study is the first of its kind to receive federal support.

"Contemporary Western medicine has always been skeptical about acupuncture," said Longhurst, who is also the Lawrence K. Dodge Professor in Integrative Biology. "But the fact remains that hundreds of millions of people worldwide benefit from this treatment, so it is our goal to bridge this gap and bring a clear medical and scientific basis for acupuncture."

Longhurst points out that, despite its long history, there has been little medical research done on acupuncture's effects on certain diseases.

A practicing cardiologist, Longhurst studies at the molecular level how acupuncture excites brain cells to release neurotransmitters that either inhibit or heighten cardiovascular activity. Acupuncture is a 3,000-year-old form of Chinese medicine that involves inserting needles at specific points on the body to help cure disease or relieve pain. When an acupuncture needle is inserted at specific sites on the wrist, inside of the forearm or leg, this triggers the release of opioid chemicals in the brain that reduce excitatory responses in the cardiovascular system, according to Longhurst. This decreases the heart's activity and its need for oxygen, which in turn lowers blood pressure and promotes healing for a number of cardiac ailm
'"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
5-Feb-2004


Page: 1 2

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group are ... than 59,229 complaints since 2004 from women claiming they suffered ... as the Mirena IUD.* , Among the most common of ... where the IUD came out on its own. There are ... article. “Abdominal pain is also common, with 3,774 complaints. And ...
(Date:5/24/2013)... 24, 2013 Gift Card Network ... competitors in sustainable card material, are combining forces ... materials as a sustainable gift card substrate. , ... industry challenges and increase education and usage of ... support the reduction of carbon footprint and environmental ...
(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...
Breaking Medicine News(10 mins):Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
(Date:5/23/2013)... Mass. , May 23, 2013  Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)...  MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
Cached News: